CCND1 and neoplasm: Survival plots showed that patients exhibiting CCND1-amplified tumours had an increased risk of recurrence compared with patients showing nonamplified tumours (HR = 2.04; 95% CI, 1.37 to 3.03; χ12 = 10.51; P < 0.001, univariate) (Figure 2a).